CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to AML
Related studies linked through entity extraction aliases.
Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Pre-emptive Immunomodulation After Allogeneic Stem Cell Transplantation in AML
- Status
- UNKNOWN
- Phase
- N/A
Chidamide Plus DCAG for Relapsed/Refractory AML
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML
- Status
- COMPLETED
- Phase
- PHASE2
Photochemotherapy and Graft-versus-leukemia in Acute-leukemia
- Status
- COMPLETED
- Phase
- N/A
Epidemiologic Registry PETHEMA LMA 2015
- Status
- UNKNOWN
- Phase
- N/A
VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years
- Status
- COMPLETED
- Phase
- N/A
Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial
- Status
- COMPLETED
- Phase
- NA
Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive
- Status
- COMPLETED
- Phase
- PHASE3